(Q34650435)

3 August 2017

Glutathione: a redox signature in monitoring EPI-743 therapy in children with mitochondrial encephalomyopathies (English)

1 reference

3 August 2017

1 reference

12

1 reference

Gianna Di Giovamberardino

3 August 2017

Sara Petrillo

2

0 references

Gianna Di Giovamberardino

7

0 references

Giulia Tozzi

Giulia Tozzi

3

0 references

Anna Pastore

Anna Pastore

1

0 references

Fiorella Piemonte

Fiorella Piemonte

13

0 references

Rosalba Carrozzo

Rosalba Carrozzo

4

0 references

Carlo Dionisi-Vici

Carlo Dionisi-Vici

6

0 references

Diego Martinelli

5

Diego Martinelli

1 reference

3 August 2017

10

Guy Miller

1 reference

3 August 2017

Ferdinando Ceravolo

8

1 reference

PubMed ID

23583222

3 August 2017

Matthew B Klein

9

1 reference

PubMed ID

23583222

3 August 2017

Gregory M Enns

11

1 reference

3 August 2017

24 March 2013

1 reference

Molecular Genetics and Metabolism

3 August 2017

1 reference

3 August 2017

109

1 reference

3 August 2017

2

1 reference

3 August 2017

208-214

1 reference

Mitochondrial energetics and therapeutics

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Subacute necrotizing encephalomyelopathy in an infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

High prevalence of SURF1 c.845_846delCT mutation in Polish Leigh patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

X-linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Molecular genetic characterization of an X-linked form of Leigh's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

X-linked Leigh's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Glutathione deficiency in patients with mitochondrial disease: implications for pathogenesis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Plasma thiol status is altered in children with mitochondrial diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Molecular mechanisms and clinical implications of reversible protein S-glutathionylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

S-Glutathionylation signaling in cell biology: progress and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Recent trends in glutathione biochemistry--glutathione-protein interactions: a molecular link between oxidative stress and cell proliferation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Glutathione dysregulation and the etiology and progression of human diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

S-glutathionylation: from molecular mechanisms to health outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

EPI-743 reverses the progression of the pediatric mitochondrial disease--genetically defined Leigh Syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Glutathione metabolism and antioxidant enzymes in children with Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Measurement of protein thiol groups and glutathione in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Initial experience in the treatment of inherited mitochondrial disease with EPI-743.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Radical-free biology of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Dysfunctions of cellular oxidative metabolism in patients with mutations in the NDUFS1 and NDUFS4 genes of complex I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Biological markers of oxidative stress in mitochondrial myopathies with progressive external ophthalmoplegia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Increased expression of manganese-superoxide dismutase in fibroblasts of patients with CPEO syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.011

10.1016/J.YMGME.2013.03.011

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

23583222